Zhou J - Search Results

1

[Clinical study of rhIL-11 for prevention and treatment of chemotherapy-induced thrombocytopenia].

Sun XF, Guan ZZ, Huang H, Zhou QH, Yi C, Zhang LJ, Zhu J, Li R, Zhou J, Zhang M, Guo Y. Sun XF, et al. Among authors: zhou qh, zhou j. Ai Zheng. 2002 Aug;21(8):892-5. Ai Zheng. 2002. PMID: 12478901 Clinical Trial. Chinese.

2

Prognostic Impact of ABO Blood Group on the Survival in Patients with Ovarian Cancer.

Zhou J, Yang LC, He ZY, Li FY, Wu SG, Sun JY. Zhou J, et al. J Cancer. 2015 Aug 8;6(10):970-5. doi: 10.7150/jca.12471. eCollection 2015. J Cancer. 2015. PMID: 26316893 Free PMC article.

3

Trends and Outcomes of Sentinel Lymph Node Biopsy in Early-stage Vulvar Squamous Cell Carcinoma: A Population-based Study.

Zhou J, Zhang WW, Chen XT, Wu SG, Sun JY, Chen QH, He ZY. Zhou J, et al. J Cancer. 2018 Apr 30;9(11):1951-1957. doi: 10.7150/jca.24044. eCollection 2018. J Cancer. 2018. PMID: 29896279 Free PMC article.

4

Influence of different treatment modalities on survival of patients with low-grade endometrial stromal sarcoma: A retrospective cohort study.

Zhou J, Zheng H, Wu SG, He ZY, Li FY, Su GQ, Sun JY. Zhou J, et al. Int J Surg. 2015 Nov;23(Pt A):147-51. doi: 10.1016/j.ijsu.2015.09.072. Epub 2015 Oct 9. Int J Surg. 2015. PMID: 26449652 Free article.

5

The local treatment modalities in FIGO stage I-II small-cell carcinoma of the cervix are determined by disease stage and lymph node status.

Zhou J, Yang HY, Wu SG, He ZY, Lin HX, Sun JY, Li Q, Guo ZW. Zhou J, et al. Cancer Med. 2016 Jun;5(6):1108-15. doi: 10.1002/cam4.687. Epub 2016 Mar 14. Cancer Med. 2016. PMID: 26990881 Free PMC article.

6

Risk factors for lymph node metastasis in ovarian cancer: Implications for systematic lymphadenectomy.

Zhou J, Sun JY, Wu SG, Wang X, He ZY, Chen QH, Li FY. Zhou J, et al. Int J Surg. 2016 May;29:123-7. doi: 10.1016/j.ijsu.2016.03.039. Epub 2016 Mar 19. Int J Surg. 2016. PMID: 27000718 Free article.

7

Number of negative lymph nodes is associated with disease-free survival in patients with breast cancer.

Wu SG, Sun JY, Zhou J, Li FY, Lin Q, Lin HX, Guan XX, He ZY. Wu SG, et al. Among authors: zhou j. BMC Cancer. 2015 Feb 7;15:43. doi: 10.1186/s12885-015-1061-z. BMC Cancer. 2015. PMID: 25880737 Free PMC article.

8

CHD1L protein is overexpressed in human ovarian carcinomas and is a novel predictive biomarker for patients survival.

He WP, Zhou J, Cai MY, Xiao XS, Liao YJ, Kung HF, Guan XY, Xie D, Yang GF. He WP, et al. Among authors: zhou j. BMC Cancer. 2012 Sep 29;12:437. doi: 10.1186/1471-2407-12-437. BMC Cancer. 2012. PMID: 23020525 Free PMC article.

9

Number of negative lymph nodes should be considered for incorporation into staging for breast cancer.

Wu SG, Wang Y, Zhou J, Sun JY, Li FY, Lin HX, He ZY. Wu SG, et al. Among authors: zhou j. Am J Cancer Res. 2015 Jan 15;5(2):844-53. eCollection 2015. Am J Cancer Res. 2015. PMID: 25973321 Free PMC article.

10

Lymph node ratio may predict the benefit of postoperative radiotherapy in node-positive cervical cancer.

Zhou J, Chen QH, Wu SG, He ZY, Sun JY, Li FY, Lin HX, You KL. Zhou J, et al. Oncotarget. 2016 May 17;7(20):29420-8. doi: 10.18632/oncotarget.8840. Oncotarget. 2016. PMID: 27105541 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54,929 results

Search Page

Filters